Home Legal Tepezza Lawsuit

Tepezza Lawsuit

Tepezza lawsuits claim that Horizon Therapeutics, the drug's manufacturer, failed to warn doctors and patients about health risks. People who took Tepezza and experienced permanent hearing loss or tinnitus are filing lawsuits.

This is an active lawsuit

See If You Qualify for a Tepezza Lawsuit

If you experienced hearing loss and tinnitus after using Tepezza, you may be entitled to compensation. Get a free case review today.

  • A+BBB Rating
  • 4.9 StarGoogle Reviews

We value your privacy. By clicking REVIEW MY CASE, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one or more of Drugwatch's trusted legal partners (including autodialed and prerecorded calls or text/SMS messages). Msg. and data rates apply. Your consent to text messaging is not required for a case review and you may opt out of text messages at any time by texting STOP. This is legal advertising.

  • A+BBB Rating
  • 4.9 StarGoogle Reviews
Last Modified: May 1, 2024
Fact Checked
Fact-Checked

Editors carefully fact-check all Drugwatch.com content for accuracy and quality.

Drugwatch.com has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Why Trust DrugWatch?

Drugwatch.com has been empowering patients for more than a decade

Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.

Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.

The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.

About Drugwatch.com

  • Assisting patients and their families since 2008.
  • Helped more than 12,000 people find legal help.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed medical and legal information site.
Learn More About Us

Testimonials

"Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her."
Marianne Zahren Patient’s Family Member
  • Google Business Rating
  • BBB A+ Rating Logo

Latest Tepezza Lawsuit Updates

As of May 2024, 113 Tepezza cases were pending in the MDL. Tepezza lawsuits are in the early stages, and there have been no trials scheduled or court-approved settlements yet.

The plaintiffs filed a motion to consolidate the cases in multidistrict litigation in the United States District Court for the Northern District of California in March 2023. In June 2023, judges created an MDL in the Northern District of Illinois.

  • December 2023: The MDL in Illinois had 71 pending cases related to Tepezza — an increase of 12 over November — but there have been no court-approved settlements or trials.
  • August 2023: As of August 22, 2023, 46 Tepezza cases were pending in the MDL.
  • July 2023: The newly formed MDL reported 42 pending Tepezza cases.
  • June 2023: The MDL Panel consolidated the Tepezza cases from across the country into an MDL under Judge Thomas M. Durkin of Chicago.
  • May 2023: The Panel on Multidistrict Litigation was scheduled to hear oral arguments for or against the motion to consolidate Tepezza lawsuits.
  • April 2023: Horizon filed a motion in opposition to forming an MDL in California.
  • March 2023: Plaintiffs filed a motion to transfer and consolidate cases in an MDL in California.
  • October 2022: Horizon filed a motion to dismiss Weibel’s complaint.
  • August 2022: Daniel Weibel became one of the first plaintiffs to file a Tepezza lawsuit in Illinois after he claimed the drug caused permanent hearing loss and tinnitus.

Horizon opposed moving cases to California. However, the company said that if the court rules in favor of consolidation, cases should be consolidated in Illinois because a group of Tepezza lawsuits already exists in the state.

Ultimately, the multidistrict litigation panel voted to move the cases to Illinois. The cases will move forward in discovery next.

What Are Tepezza Lawsuits?

People are filing Tepezza lawsuits after they took the drug and suffered permanent hearing problems, such as hearing loss and tinnitus. According to lawsuits, the drug’s label doesn’t warn patients or doctors about the risk of hearing loss or tinnitus, and it doesn’t warn that these problems may be permanent. 

Deaf woman wearing hearing aid and using smartphone
Studies found Tepezza may cause permanent hearing loss or tinnitus.

The FDA approved Tepezza, also known as teprotumumab, to treat thyroid eye disease, or TED. The agency approved the drug in January 2020, and it’s the only drug available to treat TED. 

During clinical trials, about 10% of patients reported hearing issues. But a 2021 study found the risk could be as high as 65%. 

In July 2023, Horizon added the following warning to the drug’s label:

“Hearing Impairment Including Hearing Loss: Tepezza may cause severe hearing impairment including hearing loss, which in some cases may be permanent. Assess patients’ hearing before, during, and after treatment with Tepezza and consider the benefit-risk of treatment with patients.”

Why File a Tepezza Lawsuit?

People who took Tepezza and suffered permanent hearing loss or tinnitus may file a Tepezza lawsuit to receive compensation for medical bills, pain and suffering, lost wages and decreased quality of life. Filing a lawsuit may also help warn other patients about the risks of taking Tepezza. 

These permanent side effects of Tepezza don’t just cost money, they can also decrease a person’s quality of life. Studies show permanent hearing loss or tinnitus can make it difficult to understand others, potentially  leading to feelings of frustration, anxiety and depression. 

Tepezza Hearing Loss

In a study of 26 people who had at least four infusions of Tepezza, 23% suffered hearing loss. Study authors said hearing loss was new or worse after taking the drug.

For some patients, the symptoms went away a few months after stopping the drug. However, others continued to experience symptoms even after stopping treatment. 

Tepezza Tinnitus

In the same study, 27% of people who took Tepezza suffered tinnitus, or ringing in the ears. Some patients’ symptoms resolved after a few months. 

Study authors said they didn’t know if symptoms could be reversed in patients whose tinnitus continued after stopping treatment. 

See if You Qualify for a Lawsuit Our Partners

Our Trusted Legal Partners

Drugwatch partners with trusted law firms to help you take legal action. After submitting the form, one of Drugwatch's partners will contact you for a free case review.

simmons hanly conroy law firm logo weitz and luxenberg logo sokolove law firm logo levin papantonio rafferty law firm logo nigh goldenberg raso and vaughn law firm logo morgan & morgan logo the ferraro law firm logo meirowitz & wasserberg law firm logo

Who Qualifies to File a Tepezza Lawsuit?

You may qualify to file a Tepezza lawsuit if you took the drug and experienced permanent or persistent hearing loss or tinnitus. Only a lawyer can tell you if you qualify. 

Tepezza lawsuit questions lawyers may ask:
  • When did you use Tepezza?
  • How many infusions or treatments did you have?
  • What type of hearing problems did you experience?
  • When did a doctor diagnose you with hearing problems?
  • Did your doctor treat you for any Tepezza-related injuries?
  • Did your doctor tell you that your hearing problems may be related to Tepezza?

If you are interested in filing a Tepezza lawsuit, you should consult a Tepezza attorney right away. There are time limits to file your case. 

Depending on the state you live in, the statute of limitations for a Tepezza lawsuit could range from two to four years. Attorney consultations are free and could preserve your right to file a claim.

Tepezza Lawsuit Status

Tepezza lawsuits are still in the early stages, and there have been no jury verdicts or settlements. Attorneys are still accepting cases. 

Arizona man Daniel Weibel filed one of the first Tempezza lawsuits in August 2022 in Illinois after he took the drug and developed permanent hearing loss. 

Weibel’s lawsuit against Horizon Pharmaceuticals claimed that “numerous patient reports, scientific studies, and even Defendant’s post-marketing studies have established that Tepezza causes hearing loss. Nevertheless, Defendant failed to warn, instruct, advise, educate, or otherwise inform Tepezza users.”

After Weibel received a thyroid eye disease diagnosis, he underwent Tepezza treatment from June 2020 through September 2020. Neither he nor his treating physician were aware of the risk of permanent hearing loss or tinnitus, according to the complaint. 

Please seek the advice of a medical professional before making health care decisions.